[Prospective risk analysis in a retrocession unit: Focus on drug dispensation process].

Analyse des risques a priori en unité de rétrocession hospitalière : focus sur le processus de dispensation.

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 25 04 2019
revised: 21 06 2019
accepted: 24 06 2019
pubmed: 1 10 2019
medline: 20 11 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

Failure mode effect analysis (FMEA) improves safety in the drug life cycle. As the drug dispensation by hospital's pharmacy can be at risk, the FMEA tool has been used to evaluate and enhance the process. After detailing the process, a first FMEA has been run in 2015. Corrective actions were implemented every time criticality indexes (CI) were above 15. One year later, we have evaluated potential impacts of these actions by running a new FMEA. In 2015, 11 failure modes were prioritized (CI>15) and the total CI for the overall process was 397. Corrective actions were implemented and one year later this amount has decreased by 14% (340) with 6 failure modes still prioritized. Thus, thanks to the FMEA, risks could be identified in year "y", they were taken into account and corrected and then effectively reassessed in year "y+1". This study showed us the interest of performing FMEA analysis in the drug dispensation process by hospital. The renewal of this risk analysis after a year helped us to monitor corrective actions, to evaluate their effectiveness and to improve safety. Finally, FMEA seems to be an effective way to steer the drug dispensation process.

Identifiants

pubmed: 31564422
pii: S0003-4509(19)30044-6
doi: 10.1016/j.pharma.2019.06.006
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

12-20

Informations de copyright

Copyright © 2019 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

C Darcissac (C)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: caroline.darcissac@chu-lyon.fr.

L Duvert (L)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.

D Hoegy (D)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France; Université Claude-Bernard Lyon 1, 6, avenue Rockefeller, 69008 Lyon, France; EA 4129 parcours santé systémique, faculté de médecine Laënnec, 7-11, rue Guillaume-Paradin, 69372 Lyon cedex 08, France.

M Chappuy (M)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.

C Pivot (C)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.

A Janoly-Dumenil (A)

Pharmacie hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France; Université Claude-Bernard Lyon 1, 6, avenue Rockefeller, 69008 Lyon, France; EA 4129 parcours santé systémique, faculté de médecine Laënnec, 7-11, rue Guillaume-Paradin, 69372 Lyon cedex 08, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH